52
DAFTAR PUSTAKA
1. Beckman Coulter. Anemia Portraits Of Anemia: Understanding a Pervasive and Persistent Problem. 2013.
2. Cullis JO. Diagnosis and management of anaemia of chronic disease : current status. 2011;(May):289–300.
3. Somvanshi S, Khan NZ, Ahmad M. Anemia in chronic kidney disease patients. Clin Queries Nephrol. 2012;1(3):198–204.
4. Babitt JL, Lin HY. Mechanisms of Anemia in CKD. J Am Soc Nephrol [Internet]. 2012;23(10):1631–4.
5. Science M. Haematology what does your blood test mean ? β008;
6. Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood. 2011;118(13):3479–88.
7. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;1–15. 8. Fahrudin M. Reaksi Psikososial Terhadap Penyakit di Kalangan Anak
Penderita Talasemia Mayor di Kota Bandung. 2011;16(03):157–76.
9. Vehapoglu A, Ozgurhan G, Ay G, Demir D, Uzuner S, Nursoy MA, et al. Hematological Indices for Differential Diagnosis of Beta Thalassemia Trait and Iron Deficiency Anemia. 1970;2014.
10. Kaushansky K, Lichtman M, Prchal J, Levi MM, Press O, Burns L, et al. Williams Hematology, 9E [Internet]. McGraw-Hill Education; 2015.
11. Getta HA, Yasseen HA, Said HM. Hi & Ha, are new indices in differentiation between Iron deficiency anemia and beta-Thalassaemia trait /A Study in Sulaimani City-Kurdistan/Iraq. IOSR J Dent Med Sci Ver I [Internet]. 2015;14(7):2279–861.
12. Niazi M, Tahir M, Fazel e R, Hameed A. Usefulness of Red Cell Indices in Differentiating Microcytic Hypochromic Anemias. Gomal J Med Sci [Internet]. 2010;8(2):125–9.
13. Konthen PG, Effendi C, Soegiarto G, Baskoro A, Tjokroprawiro A, Hendromartono, et al. Pedoman Diagnosis dan Terapi. Surabaya: Rumah Sakit Umum Dokter Soetomo; 2008. 222 p.
[Internet]. 2010;74(7):1275–82.
15. Khankin E V., Mutter WP, Tamez H, Yuan HT, Karumanchi SA, Thadhani R. Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal disease. PLoS One. 2010;5(2).
16. Nemeth E, Ganz T. The role of hepcidin in iron metabolism. Vol. 122, Acta Haematologica. 2009. p. 78–86.
17. van Veldhuisen DJ, Anker SD, Ponikowski P, Macdougall IC. Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches. Nat Rev Cardiol [Internet]. 2011;8(9):485–93.
18. Muhammad A, Sianipar O. Penentuan Defisiensi Besi Anemia Penyakit Kronis Menggunakan Peran Indeks sTfR-F. Indones J Clin Pathol Med Lab. 2005;12(1):9–15.
19. Berlin T, Meyer A, Rotman-Pikielny P, Natur A, Levy Y. Soluble transferrin receptor as a diagnostic laboratory test for detection of iron deficiency anemia in acute illness of hospitalized patients. Isr Med Assoc J IMAJ. 2011;13(2):96–8.
20. Muncie HL, Campbell J. Alpha and beta thalassemia. Am Fam Physician. 2009;80(4):339–44.
21. Davey P. Medicine at a Glance [Internet]. Wiley; 2015. (At a Glance). 22. Elizabeth G, Ann MTJA. Genotype-phenotype diversity of beta-thalassemia
in Malaysia: Treatment options and emerging therapies. Med J Malaysia. 2010;65(4):256–60.
23. Nemeth E. Hepcidin and ??-thalassemiamajor. Vol. 122, Blood. 2013. p. 3– 4.
24. Cao A, Galanello R. Beta-thalassemia. Genet Med [Internet]. 2010;12(2):61–76.
25. Cohen AR, Galanello R, Pennell DJ, Cunningham MJ, Vichinsky E. Thalassemia. Hematology Am Soc Hematol Educ Program. 2004;14–34. 26. Uthman E. Hemoglobinopathies and Thalassemias. Am Board Pathol.
2014;1–18.
54
Hematol. 2002;76 Suppl 2:105–13.
28. Bunn HF, Aster JC. Pathophysiology of Blood Disorders [Internet]. Mcgraw-hill; 2010. (Lange Medical Books).
29. Kee JL. Pedoman Pemeriksaan Laboratorium dan Diagnostik. Jakarta: EGC; 2008. 50-60.
30. Jelkmann W, Seidl J. Dependence of erythropoietin production on blood oxygen affinity and hemoglobin concentration in rats. Biomed Biochim Acta. 1987;46(2-3):S304–8.
31. Hebbel RP, Eaton JW, Kronenberg RS, Zanjani ED, Moore LG, Berger EM. Human llamas. Adaptation to altitude in subjects with high hemoglobin oxygen affinity. J Clin Invest. 1978;62(3):593–600.
32. Selhub J, Morris MS, Jacques PF, Rosenberg IH. Folate-vitamin B-12 interaction in relation to cognitive impairment, anemia, and biochemical indicators of vitamin B-12 deficiency. In: Am J Clin Nutr. 2009; Feb; 89(2): 702S–706S.
33. Metz J. A high prevalence of biochemical evidence of vitamin B12 or folate deficiency does not translate into a comparable prevalence of anemia. In: Food and Nutrition Bulletin. 2008.
34. George-Gay B, Parker K. Understanding the complete blood count with differential. Vol. 18, Journal of Perianesthesia Nursing. 2003. p. 96–117. 35. Dixon LR. The complete blood count: physiologic basis and clinical usage.
J Perinat Neonatal Nurs. 1997;11(3):1–18.
36. Nurko S. Anemia in chronic kidney disease: Causes, diagnosis, treatment. Vol. 73, Cleveland Clinic Journal of Medicine. 2006. p. 289–97.
37. Longo DL, Camaschella C. Iron-Deficiency Anemia. N Engl J Med. 2015;372(19):1832–43.
38. Bordbar E, Taghipour M, Zucconi BE. Reliability of different rbc indices and formulas in discriminating between ??-thalassemia minor and other microcytic hypochromic cases. Mediterr J Hematol Infect Dis. 2015;7(1). 39. Sirichotiyakul S, Maneerat J, Sa-Nguansermsri T, Dhananjayanonda P,
for screening for ??-thalassemia-1 and ??-thalassemia traits. J Obstet Gynaecol Res. 2005;31(3):198–201.
40. Schmaier AH, Maurer HM, Johnston CL, Scott RB. Alpha thalassemia screenign in neonates by mean corpuscular volume and mean corpuscular hemoglobin determination. J Pediatr. 1973;83(5):794–7.
41. Dhaliwal G, Cornett PA, Tierney LM. Hemolytic anemia. Vol. 69, American Family Physician. 2004. p. 2599–606.
42. Eivazi-Ziaei J, Dastgiri S, Pourebrahim S, Soltanpour R. Usefulness of red blood cell flags in diagnosing and differentiating thalassemiatrait from iron-deficiency anemia. Hematology. 2008;13(4):253–6.
43. Vayá A, Alis R, Suescún M, Rivera L, Murado J, Romagnoli M, et al. Association of erythrocyte deformability with red blood cell distribution width in metabolic diseases and thalassemia trait. Clin Hemorheol Microcirc. 2014;(August 2015).
44. Emans ME, Van Der Putten K, Van Rooijen KL, Kraaijenhagen RJ, Swinkels D, Van Solinge WW, et al. Determinants of Red Cell Distribution Width (RDW) in cardiorenal patients: RDW is not related to erythropoietin resistance. J Card Fail. 2011;17(8):626–33.
45. Ehsani MA, Shahgholi E, Rahiminejad MS, Seighali F, Rashidi A. A new index for discrimination between iron deficiency anemia and beta-thalassemia minor: Results in 284 patients. Pakistan J Biol Sci. 2009;12(5):473–5.
56
Lampiran 3. Hasil OutputSPSS
Descriptives
Kelompok Statistic Std. Error
Hb GGK Mean 9,555 ,2552
95% Confidence Interval for Mean
Lower Bound 9,039
Upper Bound 10,071
5% Trimmed Mean 9,512
Median 9,330
Thal Mean 6,342 ,1805
95% Confidence Interval for Mean
Lower Bound 5,977
Upper Bound 6,708
5% Trimmed Mean 6,333
Median 6,200
Ht GGK Mean 28,739 ,8552
95% Confidence Interval for Mean
Lower Bound 27,011 Upper Bound 30,468
5% Trimmed Mean 28,578
64
Skewness ,410 ,369
Kurtosis -,219 ,724
Thal Mean 18,655 ,5412
95% Confidence Interval for Mean
Lower Bound 17,560 Upper Bound 19,750
5% Trimmed Mean 18,739
Median 18,550
RBC GGK Mean 3,250 ,0855
95% Confidence Interval for Mean
Lower Bound 3,077
Upper Bound 3,423
5% Trimmed Mean 3,235
Median 3,190
Thal Mean 3,215 ,1157
95% Confidence Interval for Mean
Lower Bound 2,980
Upper Bound 3,449
5% Trimmed Mean 3,209
Median 3,240
MCH GGK Mean 29,349 ,3779
Interval for Mean Upper Bound 30,113
5% Trimmed Mean 29,444
Median 30,000
Thal Mean 20,713 ,7577
95% Confidence Interval for Mean
Lower Bound 19,180 Upper Bound 22,245
5% Trimmed Mean 20,592
Median 19,900
MCV GGK Mean 88,573 ,9170
95% Confidence Interval for Mean
Lower Bound 86,720 Upper Bound 90,426
5% Trimmed Mean 88,620
Median 88,500
Thal Mean 59,950 1,7481
95% Confidence Interval for Mean
Lower Bound 56,414 Upper Bound 63,486
5% Trimmed Mean 60,153
Median 60,000
66
RDW GGK Mean 14,261 ,2399
95% Confidence Interval for Mean
Lower Bound 13,776 Upper Bound 14,746
5% Trimmed Mean 14,242
Median 14,300
Thal Mean 20,947 ,7353
95% Confidence Interval for Mean
Lower Bound 19,460 Upper Bound 22,435
5% Trimmed Mean 20,953
Median 22,350
MI GGK Mean 28,0365776 ,80293708
95% Confidence Interval for Mean
Lower Bound 26,4137813 Upper Bound 29,6593740
5% Trimmed Mean 27,9772257
Interquartile Range 7,05915
Skewness ,212 ,369
Kurtosis -,450 ,724
Thal Mean 20,2439720 1,23602291
95% Confidence Interval for Mean
Lower Bound 17,7438797 Upper Bound 22,7440643
5% Trimmed Mean 20,0038442
Median 18,8786566
RDWI GGK Mean 399,6458953 13,25216740
95% Confidence Interval for Mean
Lower Bound 372,8622659 Upper Bound 426,4295247
5% Trimmed Mean 396,6243595
Median 391,1250000
Thal Mean 402,0194989 18,27417326
95% Confidence Interval for Mean
Lower Bound 365,0564946 Upper Bound 438,9825032
5% Trimmed Mean 402,5511407
Median 412,1245137
68
95% Confidence Interval for Mean
Lower Bound 123,3862762 Upper Bound 141,4081312
5% Trimmed Mean 131,6533353
Median 130,2597403
Thal Mean 138,4947192 6,62445752
95% Confidence Interval for Mean
Lower Bound 125,0954891 Upper Bound 151,8939492
5% Trimmed Mean 138,7579867
Median 137,5421443
HA GGK Mean 14,3743408 1,06106559
95% Confidence Interval for Mean
Lower Bound 12,2298472 Upper Bound 16,5188343
5% Trimmed Mean 14,1271579
Median 13,0497182
Thal Mean 23,8086445 2,28235621
95% Confidence Interval for Mean
Lower Bound 19,1921434 Upper Bound 28,4251457
5% Trimmed Mean 22,9965253
Variance 208,366
LgMI GGK Mean 1,4405 ,01261
95% Confidence Interval for Mean
Lower Bound 1,4150 Upper Bound 1,4660
5% Trimmed Mean 1,4416
Median 1,4519
Thal Mean 1,2747 ,02677
95% Confidence Interval for Mean
Lower Bound 1,2205 Upper Bound 1,3288
5% Trimmed Mean 1,2776
Median 1,2759
LgHA GGK Mean 1,1086 ,03334
95% Confidence Interval for Mean
Lower Bound 1,0412 Upper Bound 1,1760
5% Trimmed Mean 1,1137
Median 1,1156
Variance ,046
Std. Deviation ,21347
70
Thal Mean 1,2958 ,04358
95% Confidence Interval for Mean
Lower Bound 1,2077 Upper Bound 1,3839
5% Trimmed Mean 1,2998
Median 1,2743 Statistic df Sig. Statistic df Sig.
Thal ,160 40 ,012 ,916 40 ,006
LgMI GGK ,092 41 ,200* ,977 41 ,576
Thal ,068 40 ,200* ,976 40 ,530
LgHA GGK ,074 41 ,200* ,978 41 ,602
Thal ,082 40 ,200* ,973 40 ,456
*. This is a lower bound of the true significance. a. Lilliefors Significance Correction
T-Test
Group Statistics
Kelompok N Mean Std. Deviation
Std. Error Mean
LgMI GGK 41 1,4405 ,08075 ,01261
Thal 40 1,2747 ,16929 ,02677
RDWI GGK 41 399,6458953 84,85527428 13,25216740
Thal 40 402,0194989 115,57601970 18,27417326
HI GGK 41 132,3972037 28,54821184 4,45848164
Thal 40 138,4947192 41,89674803 6,62445752
LgHA GGK 41 1,1086 ,21347 ,03334
Thal 40 1,2958 ,27559 ,04358
Independent Samples Test
t-test for Equality of Means
Sig. (2-LgMI Equal variances
assumed ,000 ,16581 ,02936 ,10738
Equal variances not
72
RDWI Equal variances
assumed ,916 Equal variances not
assumed ,917 HI Equal variances
assumed ,445 Equal variances not
assumed ,448 LgHA Equal variances
assumed ,001 -,18720 ,05469 -,29607
Equal variances not
assumed ,001 -,18720 ,05487 -,29654
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference Upper
LgMI Equal variances assumed ,22424
Equal variances not assumed ,22509
RDWI Equal variances assumed 42,38999368
Equal variances not assumed 42,63111157
HI Equal variances assumed 9,72385468
Equal variances not assumed 9,83390365
LgHA Equal variances assumed -,07834
Equal variances not assumed -,07787
Group Statistics
Kelompok N Mean Std. Deviation
Std. Error Mean
Hb GGK 41 9.555 1.6342 .2552
Thal 40 6.343 1.1415 .1805
Ht GGK 41 28.739 5.4762 .8552
Thal 40 18.655 3.4231 .5412
Thal 40 3.214 .7318 .1157
MCH GGK 41 29.349 2.4198 .3779
Thal 40 20.712 4.7919 .7577
RDW GGK 41 14.261 1.5362 .2399
Thal 40 20.948 4.6507 .7353
Independent Samples Test Levene's Test for Equality
of Variances
t-test for Equality of Means
F Sig. t df
Hb Equal variances
assumed 4.296 .041 10.233 79
Equal variances not
assumed 10.278 71.637
Ht Equal variances
assumed 4.508 .037 9.909 79
Equal variances not
assumed 9.963 67.372
RBC Equal variances
assumed 2.608 .110 .246 79
Equal variances not
assumed .245 72.215
MCH Equal variances
assumed 24.297 .000 10.276 79
Equal variances not
assumed 10.200 57.358
RDW Equal variances
assumed 56.566 .000 -8.732 79
Equal variances not
assumed -8.645 47.223
Independent Samples Test
t-test for Equality of Means
(2-74
Hb Equal variances
assumed .000 3.2126 .3139 2.5878
Equal variances not
assumed .000 3.2126 .3126 2.5894
Ht Equal variances
assumed .000 10.0840 1.0177 8.0584
Equal variances not
assumed .000 10.0840 1.0121 8.0641
RBC Equal variances
assumed .806 .0353 .1434 -.2501
Equal variances not
assumed .807 .0353 .1439 -.2515
MC H
Equal variances
assumed .000 8.6363 .8404 6.9635
Equal variances not
assumed .000 8.6363 .8467 6.9411
RD W
Equal variances
assumed .000 -6.6865 .7658 -8.2107
Equal variances not
assumed .000 -6.6865 .7735 -8.2424
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference Upper
Hb Equal variances assumed 3.8375
Equal variances not assumed 3.8358
Ht Equal variances assumed 12.1096
Equal variances not assumed 12.1040
RBC Equal variances assumed .3206
Equal variances not assumed .3220
MCH Equal variances assumed 10.3091
Equal variances not assumed 10.3315
RDW Equal variances assumed -5.1623
Equal variances not assumed -5.1307
Mann-Whitney Test
MCV GGK 41 60.95 2499.00
Thal 40 20.55 822.00
Total 81
76
Lampiran 4. Dokumentasi Penelitian
78
Lampiran 5. Riwayat Hidup Peneliti Identitas
Nama : Yoanita Pratiwi B
NIM : 22010112130146
Tempat / Tanggal Lahir : Semarang / 24 November 1994
Jenis Kelamin : Perempuan
Alamat : Jl. Sompok 20 Semarang
Nomor Telepon / HP : (024) 8411967 / 081325856338 Alamat email : yoanitabudiwiyono@yahoo.com
Riwayat Pendidikan Formal
1) SD Marsudirini Semarang Lulus tahun :2006
2) SMP PL Domenico Savio Semarang Lulus tahun :2009 3) SMA Karangturi Semarang Lulus tahun :2012 4) Fakultas Kedokteran Universitas Diponegoro Masuk tahun :2012
Keanggotaan Organisasi
1) Koordinator Sie Konsumsi Paskah PRMK PMKK 2013 2) Koordinator Sie Konsumsi Natal PRMK PMKK 2013 3) Sie Dana Usaha Porseni 2014
4) Sie Dana Usaha Kemah Bakti 2015
